Fresenius Medical Care stock holds near $24 after buybacks
Published on 08/14/2026 at 07:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Fresenius Medical Care AG & Co. KGaA (ISIN DE0005785802) stock closed at $23.71 on August 12, 2026, down $0.16 or 0.67 percent, while a fresh August 13, 2026 capital market update put share repurchases back in view.
The same market snapshot also showed a Europe-listed quote of EUR 57.06 on August 13, 2026, down EUR 0.16 or 0.28 percent, which keeps the move contained even after the latest corporate disclosure.
Buybacks keep the story alive
The capital market information release dated August 13, 2026 details recent repurchases and trading activity in the company's own shares, including the number of acquired shares, the weighted average purchase price in EUR, and the total transaction value. That makes the buyback the clearest current corporate catalyst in the available evidence.
For investors, the more important point is that the stock is not reacting to a one-day headline spike. It is trading with a narrow daily move and a clear corporate action behind it.
Results still set the baseline
On August 3, 2026, the company reported quarterly earnings of $0.66 per share on revenue of $5.55 billion, both above expectations of $0.62 and $5.48 billion. The beat was modest, but it gave the share count and capital return angle more room to matter.
A later market summary also listed a $23.57 average price target, six Hold ratings, five Sell ratings, and a 52-week range of $20.02 to $27.64, which leaves the stock in the middle of a cautious analyst setup.
Product angle
Fresenius Medical Care's dialysis business remains centered on treatment services, dialysis products, and care delivery for chronic kidney failure patients. That operating mix still matters because it ties revenue quality to treatment volumes, reimbursement trends, and capital discipline.
Price and position
Fresenius Medical Care stock last traded at $23.71 on August 12, 2026, with a market capitalization of $12.74 billion and a 50-day moving average of $23.78. The 200-day moving average stood at $23.07, leaving the shares close to both trend lines rather than stretched away from them.
Fact box
Company: Fresenius Medical Care AG & Co. KGaA
ISIN: DE0005785802
Ticker: FMS
Exchange: NYSE
Sector / Industry: Health Care / Health Care Equipment & Supplies
Market cap: $12.74 billion
Price (as of August 12, 2026, 3:57 p.m. ET): $23.71 USD
Next earnings date: August 3, 2026
